LPL Financial’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

LPL Financial’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,211	Closed	-$383K	–	5063
2023 Q4	$383K	Buy	+1,211	New	+$235K	﹤0.01%	3888
2023 Q3	–	Sell	-1,071	Closed	-$232K	–	4819
2023 Q2	$232K	Sell	1,071 -329	-24%	-$70.5K	﹤0.01%	4045
2023 Q1	$254K	Buy	+1,400	New	+$268K	﹤0.01%	3873

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

LPL Financial's KRTX Position: Q1 2024 in Review

LPL Financial sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,211 shares — an estimated $383K sold.

LPL Financial first reported a position in KRTX in Q1 2023 and held it in 3 quarters. The position peaked at $383K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

LPL Financial reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
LPL Financial sold 1,211 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $383K.
LPL Financial first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
LPL Financial's Karuna Therapeutics, Inc. Common Stock position peaked at $383K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on LPL Financial's 13F filing for Q1 2024, filed 10 May 2024.